BOBULSKY SUSAN

Chief Commercial Officer, MRD

BOBULSKY SUSAN has filed 11 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2026. 11 of those filings fall inside the rolling window. Most recent filing: Oct 8, 2026.

On the most recent filing, BOBULSKY SUSAN is listed as Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp. Inside the rolling window, BOBULSKY SUSAN reported no open-market purchases and 10 open-market sales totaling $1.4M in ADPT. The largest disclosed transaction in the window is a sale of 41,338 ADPT shares on Mar 11, 2026, worth $544K.

Companies traded

Other insiders at ADPT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ADPTSale$193KOct 8SEC ↗
ADPTSale$32KSep 17SEC ↗
ADPTSale$75KAug 12SEC ↗
ADPTSale$31KAug 3SEC ↗
ADPTSale$115KJul 20SEC ↗
ADPTSale$11KJul 6SEC ↗
ADPTSale$103KJun 29SEC ↗
ADPTSale$95KJun 15SEC ↗
ADPTSale$198KJun 9SEC ↗
ADPTSale$544KMar 13SEC ↗
Showing 1–10 of 10
1 / 1

Frequently asked questions

How many SEC Form 4 filings has BOBULSKY SUSAN made?

BOBULSKY SUSAN has filed 11 SEC Form 4 filings (12 transaction rows) across 1 company since 2026.

Which companies does BOBULSKY SUSAN trade?

BOBULSKY SUSAN has filed SEC Form 4 disclosures for 1 company, including ADPT.

When was BOBULSKY SUSAN's most recent SEC Form 4 filing?

BOBULSKY SUSAN's most recent SEC Form 4 filing on Tracefour is dated Oct 8, 2026.

What is BOBULSKY SUSAN's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, BOBULSKY SUSAN is listed as Chief Commercial Officer, MRD.

What is BOBULSKY SUSAN's total buy and sell value in the current window?

Inside the rolling retention window, BOBULSKY SUSAN bought $0 and sold $1.4M based on SEC Form 4 filings.

What was BOBULSKY SUSAN's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 41,338 ADPT shares on 2026-03-11, worth $544K, per SEC Form 4 filings.